Asparaginase News and Research

RSS
Asparaginase is a drug which is given at the same time as chemotherapy drugs. It is an enzyme which deprives leukaemia cells of essential nutrients so that they die.
Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA receives FDA Priority Review status for ERWINAZE BLA

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

Researchers develop new technique to reduce acrylamide in French fries

Researchers develop new technique to reduce acrylamide in French fries

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

ERYtech Pharma receives ODD for its GRASPA from FDA

ERYtech Pharma receives ODD for its GRASPA from FDA

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

Discovery 'significant step' in understanding leukaemia drug resistance

Discovery 'significant step' in understanding leukaemia drug resistance

New hope for common form of childhood cancer

New hope for common form of childhood cancer

New hope for childhood cancer sufferers

New hope for childhood cancer sufferers

Leukemic cells find safe haven in bone marrow

Leukemic cells find safe haven in bone marrow

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Gene expression pattern predicts multiple drug resistance

Gene expression pattern predicts multiple drug resistance

Researchers step closer to cure for common childhood cancer

Researchers step closer to cure for common childhood cancer